Literature DB >> 18637900

Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis.

S L Lindsay1, S Holmes, A D Corbett, M Harker, D L Bovell.   

Abstract

BACKGROUND: Human apocrine (epitrichial) sweat glands secrete in response to local or systemic administration of catecholamines and cholinergic agonists. As the process of secretion in human apocrine glands is not fully understood and no literature detailing the expression of adrenergic, cholinergic and purinergic receptors is available, there is a need to know the receptor types. Such data could provide new approaches for the treatment of axillary bromhidrosis.
OBJECTIVES: To investigate the localization of nerve fibres, adrenergic, cholinergic and purinergic receptors in human axillary apocrine sweat glands by immunohistochemistry.
METHODS: Human axillary apocrine sweat glands were investigated by serial sectioning of paraffin wax-embedded skin samples from volunteers. Sections were examined by light microscopy and immunohistochemistry, using antibodies against neurofilament, alpha- and beta-adrenoceptors, P2Y(1), P2Y(2) and P2Y(4) purinoceptors, and M(3) cholinoceptors.
RESULTS: Neurofilaments were found near the eccrine but not the apocrine gland. Apocrine glands demonstrated the presence of beta-2 and beta-3 adrenoceptors in the secretory coil of the gland, but not alpha-1, beta-1 or M(3) receptors. Glandular purinergic staining (P2Y(1), P2Y(2) and P2Y(4)) was found in what looked like myoepithelial cells, while P2Y(1) and P2Y(2) staining was found on apical membranes and diffusely throughout secretory cells. Eccrine gland staining acted as internal positive controls.
CONCLUSIONS: No nerve fibres were found near the apocrine gland, suggesting that any catecholamine influence is through humoral effects and that glands could be influenced by beta-adrenoceptor subtypes and purinoceptors. Blockage of both these types of receptors offers a route to controlling apocrine secretion from axillary glands and reducing the opportunity for the development of bromhidrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637900     DOI: 10.1111/j.1365-2133.2008.08740.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Impact of Apocrine Gland Residue on Bromhidrosis Clinical Efficacy: A Self-controlled Case Series Study.

Authors:  Shanshan Lan; Ziran Zhao; Di Wu; Chunmei Zheng; Xue Dong; Kejia Zhang
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-11

2.  High-resolution axon reflex sweat testing for diagnosis of neuropathy.

Authors:  Adam Loavenbruck; Nathan Sit; Vincenzo Provitera; William Kennedy
Journal:  Clin Auton Res       Date:  2018-07-21       Impact factor: 4.435

3.  Rapid stress system drives chemical transfer of fear from sender to receiver.

Authors:  Jasper H B de Groot; Monique A M Smeets; Gün R Semin
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

4.  A novel organotypic 3D sweat gland model with physiological functionality.

Authors:  Patricia Klaka; Sabine Grüdl; Bernhard Banowski; Melanie Giesen; Andrea Sättler; Peter Proksch; Thomas Welss; Thomas Förster
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

5.  An elderly man with a vascular axillary mass.

Authors:  Kanthi Bommareddy; Sanjiv Kayastha; Swapna C Reddy
Journal:  JAAD Case Rep       Date:  2021-05-26

6.  Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.

Authors:  Øystein Grimstad; Bjørn Øivind Kvammen; Carl Swartling
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

7.  Sweat Gland Organoids Originating from Reprogrammed Epidermal Keratinocytes Functionally Recapitulated Damaged Skin.

Authors:  Xiaoyan Sun; Jiangbing Xiang; Runkai Chen; Zhijun Geng; Lintao Wang; Yiqiong Liu; Shuaifei Ji; Huating Chen; Yan Li; Cuiping Zhang; Peng Liu; Tao Yue; Lei Dong; Xiaobing Fu
Journal:  Adv Sci (Weinh)       Date:  2021-09-26       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.